Clinical Trial Update: An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants

View source ↗

Summary

An observational study assessing changes in migraine disease activity when ubrogepant is combined with atogepant in adult participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)
• Ubrelvy (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: COMPLETED